Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$376M |
| 2 |
Apple
AAPL
|
+$264M |
| 3 |
STJ
St Jude Medical
STJ
|
+$263M |
| 4 |
Microsoft
MSFT
|
+$260M |
| 5 |
Alibaba
BABA
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 2 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$261M |
| 3 |
Gilead Sciences
GILD
|
+$247M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$232M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.56% |
| 2 | Healthcare | 4.73% |
| 3 | Financials | 4.3% |
| 4 | Consumer Discretionary | 3.31% |
| 5 | Energy | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Home BancShares
HOMB
$6.17B
| $397K | ﹤0.01% |
20,070
+18,132
| +936% | +$380K |
|
3327
SS&C Technologies
SSNC
$18.9B
| $397K | ﹤0.01% |
14,115
+5,317
| +60% | +$159K |
|
3328
Vanguard Financials ETF
VFH
$13.7B
| $397K | ﹤0.01% |
+8,384
| New | +$398K |
|
|
AVP
3329
CALL
DELISTED
Avon Products, Inc.
AVP
| $397K | ﹤0.01% |
105,000
+47,600
| +83% | +$205K |
|
3330
Canadian Solar
CSIQ
$1.04B
| $396K | ﹤0.01% |
26,250
-5,911
| -18% | -$102K |
|
|
HCR
3331
PUT
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $396K | ﹤0.01% |
30,300
-2,600
| -8% | -$21.2K |
|
3332
Toro Company
TTC
$9.48B
| $395K | ﹤0.01% |
8,980
-6,526
| -42% | -$285K |
|
3333
PUT
Westlake Corp
WLK
$10B
| $395K | ﹤0.01% |
9,200
+4,100
| +80% | +$187K |
|
3334
Compañía de Cervecerías Unidas
CCU
$2.2B
| $394K | ﹤0.01% |
16,898
| – | – |
|
|
DNY
3335
CALL
DELISTED
DONNELLEY R R & SONS CO
DNY
| $394K | ﹤0.01% |
23,300
-22,500
| -49% | -$380K |
|
|
DF
3336
PUT
DELISTED
Dean Foods Company
DF
| $393K | ﹤0.01% |
21,700
+3,100
| +17% | +$54.9K |
|
3337
Calumet Specialty Products
CLMT
$3.43B
| $392K | ﹤0.01% |
80,074
-8,205
| -9% | -$46.5K |
|
3338
American Financial Group
AFG
$12.1B
| $391K | ﹤0.01% |
5,287
+3,400
| +180% | +$241K |
|
3339
Graham Holdings Company
GHC
$5.03B
| $391K | ﹤0.01% |
799
+529
| +196% | +$258K |
|
3340
CALL
Labcorp
LH
$25.8B
| $391K | ﹤0.01% |
3,492
-3,958
| -53% | -$426K |
|
3341
Exelixis
EXEL
$13.2B
| $390K | ﹤0.01% |
49,960
-133,977
| -73% | -$772K |
|
3342
Natural Gas Services Group
NGS
$463M
| $390K | ﹤0.01% |
17,013
-588
| -3% | -$13.2K |
|
3343
CALL
Silicon Laboratories
SLAB
$7.22B
| $390K | ﹤0.01% |
+8,000
| New | +$377K |
|
|
HDS
3344
DELISTED
HD Supply Holdings, Inc.
HDS
| $389K | ﹤0.01% |
11,178
-73,131
| -87% | -$2.49M |
|
|
FRAN
3345
DELISTED
Francesca's Holdings Corporation
FRAN
| $389K | ﹤0.01% |
2,932
-7,405
| -72% | -$1.23M |
|
3346
CALL
Ingredion
INGR
$6.57B
| $388K | ﹤0.01% |
3,000
+2,700
| +900% | +$314K |
|
3347
Hanover Insurance
THG
$7.97B
| $388K | ﹤0.01% |
4,597
-8,210
| -64% | -$706K |
|
3348
CALL
DaVita
DVA
$11.6B
| $387K | ﹤0.01% |
5,000
-2,500
| -33% | -$189K |
|
3349
CALL
Lazard
LAZ
$4.3B
| $387K | ﹤0.01% |
13,000
+11,100
| +584% | +$385K |
|
|
SBY
3350
DELISTED
Silver Bay Realty Trust Corp.
SBY
| $387K | ﹤0.01% |
22,738
-1,085
| -5% | -$16.5K |
|
Similar funds
Barclays's Q2 2016 Portfolio in Review
As of Q2 2016, Barclays held 7,054 positions worth $76.9B, up 17% from $65.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $9.16B of net new capital in Q2 2016, opening 709 new positions and adding to 2,754 existing holdings. Its largest new stake was S&P Global: 236,625 shares worth $25.4M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 5.5% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $995M trimmed.
- Barclays's largest Q2 2016 buy was S&P Global: 236,625 shares worth $25.4M.
- Barclays added most to McDonald's in Q2 2016, an estimated $376M increase.
- Barclays's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $995M.
- Barclays fully exited CAMERON INTERNATIONAL CORPORATION in Q2 2016, selling an estimated $261M.
- Barclays's ten largest holdings make up 32% of its $76.9B portfolio in Q2 2016.
- Barclays opened 709 new positions and closed 569 in Q2 2016.
- Barclays's portfolio value rose 17% quarter-over-quarter to $76.9B.
Based on Barclays's 13F filing for Q2 2016, filed 12 Aug 2016.